South Korea’s BiocurePharm To Produce Biosimilars In Thailand
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korean biopharmaceutical company BiocurePharm signed a memorandum of understanding with Thailand pharmaceutical distributor Kwang Tiang Dispensary to build a $20 million plant in Thailand to produce five types of biosimilar products for anemia and hepatitis, BiocurePharma announced Nov. 13